These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 30287142)
41. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy. Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893 [TBL] [Abstract][Full Text] [Related]
42. Angiogenic activity of hepatitis B and C viruses. Vrancken K; Paeshuyse J; Liekens S Antivir Chem Chemother; 2012 Jan; 22(4):159-70. PubMed ID: 22182803 [TBL] [Abstract][Full Text] [Related]
43. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus. Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626 [TBL] [Abstract][Full Text] [Related]
44. Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation. Ninio L; Nissani A; Meirson T; Domovitz T; Genna A; Twafra S; Srikanth KD; Dabour R; Avraham E; Davidovich A; Gil-Henn H; Gal-Tanamy M Cells; 2019 Nov; 8(11):. PubMed ID: 31694343 [TBL] [Abstract][Full Text] [Related]
45. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma. Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748 [TBL] [Abstract][Full Text] [Related]
46. Overexpression of CXCR7 induces angiogenic capacity of human hepatocellular carcinoma cells via the AKT signaling pathway. Chen Y; Teng F; Wang G; Nie Z Oncol Rep; 2016 Oct; 36(4):2275-81. PubMed ID: 27572688 [TBL] [Abstract][Full Text] [Related]
47. Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis. Ikawa T; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y Arthritis Res Ther; 2021 Nov; 23(1):283. PubMed ID: 34774095 [TBL] [Abstract][Full Text] [Related]
48. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490 [TBL] [Abstract][Full Text] [Related]
49. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production. Zeng W; Chang H; Ma M; Li Y Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269 [TBL] [Abstract][Full Text] [Related]
50. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110 [TBL] [Abstract][Full Text] [Related]
51. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. Ghadjar P; Loddenkemper C; Coupland SE; Stroux A; Noutsias M; Thiel E; Christoph F; Miller K; Scheibenbogen C; Keilholz U J Cancer Res Clin Oncol; 2008 Nov; 134(11):1181-9. PubMed ID: 18465142 [TBL] [Abstract][Full Text] [Related]
53. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997 [TBL] [Abstract][Full Text] [Related]
54. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells. Yukawa H; Suzuki K; Aoki K; Arimoto T; Yasui T; Kaji N; Ishikawa T; Ochiya T; Baba Y Sci Rep; 2018 Apr; 8(1):6765. PubMed ID: 29713019 [TBL] [Abstract][Full Text] [Related]
55. Role of the CCL20/CCR6 axis in tubular epithelial cell injury: Kidney-specific translational insights from acute kidney injury to chronic kidney disease. Yoo KD; Yu MY; Kim KH; Lee S; Park E; Kang S; Lim DH; Lee Y; Song J; Kown S; Kim YC; Kim DK; Lee JS; Kim YS; Yang SH FASEB J; 2024 Jan; 38(2):e23407. PubMed ID: 38197598 [TBL] [Abstract][Full Text] [Related]
56. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma. Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124 [TBL] [Abstract][Full Text] [Related]
57. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996 [TBL] [Abstract][Full Text] [Related]
59. Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma. Lee CF; Ling ZQ; Zhao T; Lee KR World J Gastroenterol; 2008 Oct; 14(39):6072-7. PubMed ID: 18932288 [TBL] [Abstract][Full Text] [Related]
60. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice. Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]